Different reports have demonstrated elevated serum KL-6 concentrations in various ILDs, including connective tissue disorders associated with ILD [14,15,16,17], suggesting that this marker is not only useful for diagnosis but also for prognosis and for monitoring response to therapy. The gene discussed is MUC1; the disease is interstitial lung disease.